Anagrafe della ricerca

PREMUROSA - Precision medicine for muscoloskeletal regeneration, prosthetics and active ageing

Durata:
49 mesi (2020 - 2023)
Responsabile scientifico:
Tipo di progetto:
Ricerca UE - H2020 - Excellent Science - Marie Curie
Ente finanziatore:
COMMISSIONE EUROPEA
Codice identificativo progetto:

Abstract

Muscoloskeletal diseases are a major burden on individuals, healthcare and welfare systems. Treatment of muscolo-skeletal disorders is currently based either on prosthetic or regenerative surgical procedures, often involving medical device implantation. In both cases, individual tissue healing and regeneration, together with the appropriateness of the implanted device, markedly affect the outcome. A great improvement could be achieved by precision medicine, specifically designed on patients individual characteristics. This implies to combine the personalized clinical approach with individual omic characterization and proper choice of medical device. The concept is To take care with care. This is the meaning of the Italian word premurosa and the ultimate goal of the ITN PREMUROSA project, aimed to train a new generation of scientists with an integrated vision of the whole value chain in muscolo-skeletal regeneration technologies and able to boost the necessary innovations to achieve precision principles in developing innovative devices and optimized clinical applications. This aim will be achieved by a triple i (interdisciplinary, intersectoral, international) approach of thirteen ESRs, who will benefit from an excellent scientific environment, up-date technologies and supervision by international leaders in the field. They will learn to integrate academic and industrial aspects and they will sharpen their experimental and complementary skills in a well-designed and diversified and unprecedented training program.

Persone coinvolte

Dipartimenti coinvolti

Budget

Costo totale progetto: € 3.348.405,36
Contributo totale progetto: € 3.348.405,36
Costo totale PoliTo: € 261.499,68
Contributo PoliTo: € 261.499,68